美国将华大系三家企业列入 UFLPA 实体清单,10 月 29 日起对相关货物适用「可反驳推定」US Adds Three BGI Affiliates to the UFLPA Entity List; Rebuttable Presumption Applies From Oct 29
美东时间 10 月 28 日,美国国土安全部(DHS)在《联邦公报》发布公告,把华大基因、华大智造和深圳华大基因科技有限公司列入《维吾尔强迫劳动预防法》(UFLPA)实体清单,10 月 29 日起生效。CBP 对清单实体货物适用「可反驳推定」,原则上不准入境,除非进口商提交「清晰且令人信服」的证据并通过供应链追溯核查。清单实体总数由此增至 190 家。On 28 October the US Department of Homeland Security published a Federal Register notice adding BGI Genomics, MGI Tech and Shenzhen BGI Technology to the UFLPA Entity List, effective 29 October. CBP applies a rebuttable presumption to goods from listed entities: entry is barred in principle unless the importer submits clear and convincing evidence and clears a supply-chain traceability review. The list now stands at 190 entities.
这次列单的实操意义不在「华大」本身,而在审查逻辑:UFLPA 是穿透式执法,即便成品在第三国加工,只要追溯出使用了清单实体的投入品,仍可能被扣;未被列名也不构成安全港。实验室设备、测序耗材、试剂,以及用这类设备生产出来的成品输美,布控概率会明显上升。The practical significance is less about BGI than about the enforcement logic. UFLPA looks through the chain: even where a finished good is processed in a third country, it can be detained if inputs from a listed entity are traced into it, and not being listed is no safe harbour. Detention risk rises for lab equipment, sequencing consumables, reagents and finished goods made with such equipment entering the US.
对进口商意味着什么What It Means For Importers
逐票核对供应商股权结构与最终控制方,别只看报关发票上的卖方名称;备齐采购合同、生产记录、物料来源与运输单据,能一路追到原料端;第三国简单换证解决不了问题;一旦被扣,走 CBP 排除申请程序并第一时间通知买方,避免滞港费滚雪球。Screen supplier ownership and ultimate control, not just the seller name on the invoice; keep purchase contracts, production records, material-origin and transport documents that trace back to raw materials; a third-country certificate swap will not fix it; if cargo is detained, file for a CBP exclusion and alert the buyer immediately so demurrage does not compound.
